AGE/RAGE signaling-mediated endoplasmic reticulum stress and future prospects in non-coding RNA therapeutics for diabetic nephropathy

Biomed Pharmacother. 2020 Nov:131:110655. doi: 10.1016/j.biopha.2020.110655. Epub 2020 Aug 24.

Abstract

Disturbance of endoplasmic reticulum (ER) homeostasis triggered by the accumulation of unfolded proteins and advanced glycation end-products (AGEs) plays a major role in pathophysiology of diabetic nephropathy. Activation of receptor for AGEs (RAGE) stimulates NADPH oxidase-mediated reactive oxygen species (ROS) production, leading to ER stress, inflammation, glomerular hypertrophy, podocyte injury, and renal fibrosis. A growing body of evidence indicates that non-coding RNAs (ncRNAs) could rescue ER stress and renal inflammation by the epigenetic modification. This review summarizes ncRNA regulation in AGE/RAGE signaling-mediated ER stress, and discusses the opportunities and challenges of ncRNA-loaded extracellular vesicle therapy in diabetic nephropathy.

Keywords: AGE/RAGE/Nox signaling; Diabetic nephropathy; ER stress; Extracellular vesicle delivery; RNA-based drugs.

Publication types

  • Review

MeSH terms

  • Animals
  • Diabetic Nephropathies / genetics*
  • Diabetic Nephropathies / metabolism
  • Diabetic Nephropathies / therapy*
  • Endoplasmic Reticulum Stress / physiology*
  • Forecasting
  • Genetic Therapy / methods
  • Genetic Therapy / trends
  • Glycation End Products, Advanced / genetics*
  • Glycation End Products, Advanced / metabolism
  • Humans
  • RNA, Untranslated / administration & dosage
  • RNA, Untranslated / genetics*
  • RNA, Untranslated / metabolism
  • Receptor for Advanced Glycation End Products / genetics*
  • Receptor for Advanced Glycation End Products / metabolism

Substances

  • Glycation End Products, Advanced
  • RNA, Untranslated
  • Receptor for Advanced Glycation End Products